A severe complication of intravesical bacillus Calmette-Guerin: An effect of different strains
Li Sian Low, David Scholtz, John Leyland, Shiva M. Nair
Urology Case Reports · 2021-02
Abstract
The use of intravesical BCG has improved the survival and outcomes in the treatment of bladder cancer. However, the worldwide shortage of OncoTice BCG has caused disruption and changes in treatment regimes, leading to use of alternative strains. We describe a severe complication as the result of using intravesical SII Onco BCG for the treatment bladder cancer, in an 82 year old man presenting with granulomatous epididymo-orchitis.
MeSH terms
- Medicine
- Bladder cancer
- Complication
- Economic shortage
- BCG vaccine
- Urology
- Bacillus (shape)
- Surgery
- Cancer
- Internal medicine